00925nas a2200325   4500000000100000000000100001000000100002008004100003653001500044653002500059653003100084653001100115653001500126653002400141653003200165653002100197653001600218653002700234653002100261653002500282100001300307700001200320700001300332700002100345245016500366250001500531300001400546490000700560020003200567       2022                            d10aBiomarkers10aCase-Control Studies10a*Hodgkin Disease/diagnosis10aHumans10aOdds Ratio10aPrimary health care10aUnited Kingdom/epidemiology10aHodgkin lymphoma10ablood tests10adiagnostic time window10ageneral practice10ainflammatory markers1 aM. Rafiq1 aG. Abel1 aC. Renzi1 aG. Lyratzopoulos00aInflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case-control study in patients aged ≤50 years  a2022/07/12  ae546-e5550 v72  a0960-1643 (Print)
0960-1643